Skip to content

Author

C. Strisciuglio

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

Efficacy and safety of ustekinumab and vedolizumab in very early-onset inflammatory bowel disease: A multicenter study from the pediatric inflammatory bowel disease Porto Group of ESPGHAN.

OBJECTIVE We aimed to assess vedolizumab and ustekinumab efficacy and safety in patients with very-early onset inflammatory bowel disease (VEO-IBD). METHODS A retrospective study involving 29 European and North American sites affiliated with the IBD Porto Group of European Society for Paediatric Gastroenterology Hepa...

L. Scarallo, P. Lionetti, J. Kierkuś et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.